# To Decrease Fatigue With Light Therapy

> **NCT03242902** · PHASE3 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 166 (actual)

## Conditions studied

- Hodgkin Lymphoma
- Diffuse Large B Cell Lymphoma

## Interventions

- **DEVICE:** Light therapy intensity 1
- **DEVICE:** Light therapy intensity 2

## Key facts

- **NCT ID:** NCT03242902
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-20
- **Primary completion:** 2019-11-25
- **Final completion:** 2020-08-11
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2020-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03242902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03242902, "To Decrease Fatigue With Light Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03242902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*